CLINICAL_TRIALS
trial_result
· 2019-11-13
Clinical Trial Update: Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study [Phase 2]
Summary
Phase II study reporting safety and efficacy of sorafenib in patients with advanced thyroid cancer completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto Nacional de Cancerologia, Columbia | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED